表紙
市場調查報告書

敗血症的診斷報告

Sepsis - Diagnosis Report

出版商 Boston Strategic Partners, Inc. 商品編碼 557097
出版日期 內容資訊 英文 55 Pages
訂單完成後即時交付
價格
敗血症的診斷報告 Sepsis - Diagnosis Report
出版日期: 2017年07月31日內容資訊: 英文 55 Pages
簡介

本報告提供敗血症的診斷趨勢的相關調查,盛行率,住院期間,費用,患者人口的統計,藥物抗性敗血症,住院期間與死亡率,轉換期等各種資料、統計彙整

第1章 概要

第2章 摘要整理

第3章 盛行率、疾病的影響

  • 盛行率
  • 住院期間
  • 整體費用

第4章 患者人口統計

  • 年齡
  • 保險類型
  • 性別
  • 地區
  • 死亡率
  • 並存症

第5章 患者區分:各診斷檢查

  • 病原體

第6章 住院期間、費用:各患者種類

  • 住院時的年齡
  • APACHE II 評分 (預後預測法)
  • 最初照護舞台裝置

第7章 醫院的患者流動

  • 住院網站
  • 臨床檢驗
  • 週轉時間
  • 結果
  • 病因

第8章 藥物抗性敗血症

  • 目前趨勢
  • 成本
  • 合併症
  • LOS (住院日數)
  • 死亡率

第9章 資料庫概要

第10章 調查手法

目錄

In 2014, US healthcare spending exceeded $3.0 trillion with nearly 1/3 spent on hospitalizations. Informed by real-world data from an Electronic Health Record (EHR) database of clinical and administrative records spanning 273 million encounters for 60 million patients in 600+ hospitals across the US, Boston Strategic Partners (BSP) Real World data report, Hospital-Treated Sepsis: Diagnosis, estimates 30% of all hospital discharges involve treatment of infectious organisms. Sepsis is responsible for an estimated 12% of all hospital stays. At an average cost of $15,500 per occurrence, we estimate that hospitalizations for severe infections account for $212 billion in annual spending or 7% of total healthcare expenditure. In this report, we conduct an in-depth analysis of sepsis patient characteristics, costs, and laboratory testing.

Hospital-Treated Sepsis: Diagnosis

Gram-positive bacteria are the likely causative agents of most sepsis infections. From 2010-2015, drug resistant organisms caused an astonishing 40% of bacterial sepsis infections. Hospital-Treated Sepsis: Diagnosis is part one of a two-part series on hospital-treated sepsis. This report provides quantitative, objective data focused on the diagnosis of sepsis requiring hospitalization. The data provides real-world patient encounters and reflects real physician diagnostic decisions and encounter characteristics (e.g. admissions and lab testing) in key areas, such as antibiotic resistant pathogens.

Table of Contents

1. Outline

2. Executive Summary

3. Incidence and Impact of Disease

  • a. Incidence
  • b. Length of Stay
  • c. Total Cost

4. Patient Demographics

  • a. Age
  • b. Insurance type
  • c. Gender
  • d. Region
  • e. Mortality
  • f. Comorbid Conditions

5. Patient Segmentation by Diagnostic Testing

  • a. Causative Etiologic Agent

6. Length of Stay and Cost by Patient Segment

  • a. Age at Admission
  • b. APACHE II Score
  • c. First Care Setting

7. Patient Flow through the Hospital

  • a. Admission Site
  • b. Lab Testing
  • c. Lab TAT
  • d. Results
  • e. Etiology

8. Drug Resistant Sepsis

  • a. Current Trends
  • b. Costs
  • c. Comorbidity
  • d. LOS
  • e. Mortality

9. Database Overview

10. Methodology